Long-term use of anagrelide in the treatment of children with essential thrombocythemia [1]

European Journal of Haematology

Volumn 77, Issue 4, 2006, Pages 358-359

  Lackner, Herwig ^a   Urban, Christian ^a   Benesch, Martin ^a   Moser, Andrea ^a   Sovinz, Petra ^a   Schwinger, Wolfgang ^a   Dornbusch, Hans Jürgen ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANAGRELIDE; ANTICOAGULANT AGENT;

ADOLESCENT; CASE REPORT; CHILD; DRUG TOLERANCE; FEMALE; FOLLOW UP; HUMAN; LETTER; LONG TERM CARE; LUNG EMBOLISM; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REMISSION; THROMBOCYTE COUNT; THROMBOCYTHEMIA; TREATMENT DURATION; WEANING;

ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; QUINAZOLINES; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 33748370548     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00719.x     Document Type: Letter

References (12)

1. DAME C, SUTOR AH. Primary and secondary thrombocytosis in childhood. Br J Haematol 2005;129:165-177.
2. HASLE H. Incidence of essential thrombocythaemia in children. Br J Haematol 2000;110:751.
3. DROR Y, BLANCHETTE VS. Essential thrombocythemia in children. Br J Haematol 1999;107:691-698.
4. HARRISON CN, CAMPBELL PJ, BUCK G, et al. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 2005;353:33-45.
5. CHINTAGUMPALA MM, KENNEDY L, STEUBER P. Treatment of essential thrombocythemia with anagrelide. J Pediatr 1995;127:495-498.
6. LACKNER H, URBAN C, BEHAM-SCHMID C, BENESCH M, KERBL R. Treatment of children with anagrelide for thrombocythemia. J Pediatr Hematol Oncol 1998;20:469-473.
7. SCHERER S, FERRARI R, RISTER M. Treatment of essential thrombocythemia in childhood. Pediatr Hematol Oncol 2003;20:361-365.
8. KRATZ CP, ABD EL-MONHEIM A, MANKE EM, RISTER M, ROGGE T, NIEMEYER CM. Retrospective analysis of the clinical course of 12 children given the diagnosis essential thrombocythemia. Klin Paediatr 2004;216:349-355.
9. MURPHY S, PETERSON P, ILAND H, LASZLO J. Experience of the Polycythemia Vera Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997;34:29-39.
10. RANDI ML, PUTTI MC, FABRIS F, SAINATI L, ZANESCO L, GIROLAMI A. Features of essential thrombocythaemia in childhood: a study of five children. Br J Haematol 2000;108:86-89.
11. YANG RC, QIAN LS, Essential thrombocythaemia in children: a report of nine cases. Br J Haematol 2000;110:1009-1010.
12. CAMPBELL PJ, SCOTT LM, BUCK G, et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet 2005;366:1945-1953.